Table 4.

Subgroup PASS thresholds estimated using weighted predictive modelling with hip-specific patient satisfaction as anchor for FJS and OHS, and EQ-VAS as anchor for the EQ-5D-5L. Values in parentheses are 95% confidence interval

PROMs		3-months data		12-months data
	Subgroup	n	PASS	n	PASS
FJS	Gender
	Female	1165	31.3 (28.6–33.0)	1110	37.0 (35.1–41.7)
	Male	870	34.4 (30.3–37.2)	829	43.5 (37.6–47.0)
	Age
	≤ 69 years	973	29.3 (25.7–31.5)	940	38.2 (33.6–42.0)
	> 69 years	1062	35.7 (32.6–37.8)	999	41.8 (37.8–44.7)
OHS	Gender
	Female	1165	31.3 (28.7–32.0)	1110	34.1 (33.0–36.5)
	Male	870	31.5 (30.6–34.3)	829	36.4 (34.3–37.7)
	Age
	≤ 69 years	973	31.9 (29.1–33.0)	940	36.6 (33.7–37.4)
	> 69 years	1062	30.8 (29.3–32.9)	999	35.3 (33.5–36.4)
EQ-5D-5 L	Gender
	Female	1104	0.811 (0.795–0.825)	1047	0.865 (0.835–0.867)
	Male	833	0.815 (0.793–0.822)	785	0.867 (0.851–0.906)
	Age
	≤ 69 years	926	0.811 (0.792–0.822)	896	0.865 (0.846–0.881)
	> 69 years	1011	0.817 (0.796–0.824)	936	0.858 (0.838–0.872)

FJS, forgotten joint score; OHS, oxford hip score; EQ-5D-5L, EuroQol five dimension five level; n, sample size.